Skip to main content

Year: 2024

Absecon Bancorp Declares Fourth-Quarter Cash Dividend of $0.90 Per Share

ABSECON, N.J., Dec. 06, 2024 (GLOBE NEWSWIRE) — Absecon Bancorp (the “Company”) (OTC, trading as ASCN), the bank holding company of First National Bank of Absecon, an Atlantic County New Jersey based community bank, announced today that its Board of Directors declared a regular quarterly cash dividend in the amount of $0.90 per share, payable on December 30, 2024 to shareholders of record as of December 17, 2024. The First National Bank of Absecon, a nationally chartered bank headquartered in Absecon, New Jersey, has a long history of serving the community since its establishment in 1916. The company is a community bank focused on providing deposit and loan products to retail customers and to small and mid-sized businesses from its primary market area in Atlantic County, New Jersey, and secondary markets consisting of portions...

Continue reading

Extraordinary General Meeting announcement

Amsterdam, December 6, 2024 SBM Offshore announces that the agenda of the Extraordinary General Meeting of Shareholders (EGM) and the invitation for shareholders to attend the EGM have now been published on the Company’s website. The EGM will be held at the Sheraton Amsterdam Airport Hotel, Schiphol Boulevard 101, 1118 BG Amsterdam, the Netherlands on Friday January 17, 2025 at 3.30 p.m. Central European Time.          Corporate Profile SBM Offshore is the world’s deepwater ocean-infrastructure expert. Through the design, construction, installation, and operation of offshore floating facilities, we play a pivotal role in a just transition. By advancing our core, we deliver cleaner, more efficient energy production. By pioneering more, we unlock new markets within the blue economy. More than 7,400 SBMers collaborate worldwide to deliver...

Continue reading

Shepherd Ave Capital Acquisition Corp Announces Closing of Initial Public Offering

Wilmington, DE, Dec. 06, 2024 (GLOBE NEWSWIRE) — Shepherd Ave Capital Acquisition Corporation (NASDAQ: SPHAU) (“SPHA” or the “Company”) announced today that it closed its initial public offering of 8,625,000 units at a price of $10.00 per unit, for aggregate gross proceeds of $86,250,000. The offering size reflects the full exercise of the underwriter’s over-allotment option. Each unit consists of one of the Company’s Class A ordinary shares (the “Class A Ordinary Shares”) and one right (the “Rights”), with each whole right entitling the holder thereof to receive one-fifth (1/5th) of one Class A Ordinary Share upon the consummation of an initial business combination. No fractional rights will be issued upon separation of the units and only whole rights will trade. The units are listed on the Nasdaq Global Market LLC (“Nasdaq”)...

Continue reading

Notification on transactions concluded by a person associated to a management body of Grigeo Group AB

Grigeo Group AB has received notifications on transactions in issuer’s securities concluded by a legal entity associated to a management body of Grigeo Group AB (see attachments). Tomas JozonisChief Executive Officer +370 5 243 58 01AttachmentsNotification on manager transactions 2024 12 03Notification on manager transactions 2024 12 04Notification on manager transactions 2024 12 05

Continue reading

Spineway provides an update on its activities during a webinar – Arrival of a new CFO

Press release         Ecully, December 6, 2024 – 6 p.m. Spineway provides an update on its activities during a webinarArrival of a new CFO The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, held a webinar on Thursday, December 5, during which Stéphane Le Roux, CEO of Spineway, reviewed the Group’s latest developments and confirmed its roadmap for the coming years. The webinar was also an opportunity to present the Group’s new Chief Financial Officer, Erwan Martin, who joined Spineway at the beginning of November. A graduate of the TBS Education Management School (Toulouse, France) and holder of an MBA from Warwick University (England), Erwan has more than 20 years of experience as a Chief Financial and Administrative Officer in the medtech and biotech sectors, leading finance teams in companies...

Continue reading

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

A 30% reduction in long episodes was shown to be associated with a 50% or greater reduction in clinical seizures in a post-hoc analysis, validating the biomarker for proof-of-concept studies Change in long episode frequency is the primary endpoint for Rapport’s ongoing Phase 2a proof-of-concept trial in focal epilepsy, with topline data expected in mid-2025 Data from additional studies, including preclinical seizure data and Phase 1 pharmacokinetic and safety trial results, support the potential of RAP-219 as a transformational treatment for patients with focal epilepsy BOSTON and LOS ANGELES, Dec. 06, 2024 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients suffering from central nervous...

Continue reading

Initiation of Restructuring Processes for a part of Companies controlled by AUGA group, AB

As announced on 11 November, 2024, AUGA group, AB (hereinafter – the Company) by the decision of the Board initiated the restructuring process of the Company, which was approved by the Extraordinary Meeting of Shareholders of the Company on 4 December, 2024.  Additionally, the Board of the Company recommended to the managers of the group companies controlled by the Company to assess the need to initiate restructuring processes for individual companies of the Company’s group. The group companies conducted an analysis on the impact of the initiation of the restructuring of the Company on the business continuity and financial situation for a particular company in question. The companies impacted by such a process-initiated negotiations with the creditors on the revision of the terms for the fulfillment of obligations in a contractual...

Continue reading

LECTRA: Monthly declaration of the total number of shares and voting rights composing the company’s capital (at November 30th, 2024)

Monthly declaration of the total number of shares and voting rights composing the company’s capital (at November 30th, 2024) This declaration is established in accordance with Article L.233-8 II of the French Code de Commerce and of Article 223-11 of the Règlement Général of the Autorité des marchés financiers (AMF). Date: November 30th, 2024 Total number of shares composing the capital: 37,964,212 Total number of voting rights, gross (1): 38,156,362 Total number of voting rights, net (2): 38,122,289 (1) In accordance with the second paragraph of article 223-11 of the Règlement Général of the AMF, the gross total of voting rights is based on the total number of shares composing the company’s capital which have voting rights, including shares deprived of their voting rights (2) The net total of voting rights is equal to the gross...

Continue reading

40/2024・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them

Company announcement no. 40 / 2024 Schindellegi, Switzerland – 6 December 2024 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by a person or entity closely associated with a person discharging managerial responsibilities in Trifork.1. Details of the person discharging managerial responsibilities/person closely associateda) Name Jørn Larsen2. Reason for the notificationa) Position/status CEOb) Initial notification/ Amendment Initial notification3. Details of the issuer, emission allowance market participant, auction platform, auctioneer...

Continue reading

Linkers Industries Limited Announced Closing of Initial Public Offering

New York, Dec. 06, 2024 (GLOBE NEWSWIRE) — Linkers Industries Limited (Nasdaq: LNKS) (the “Company”), a manufacturer and a supplier of wire/cable harnesses with operation in Malaysia, today announced the closing of its initial public offering (the “Offering”) of 1,900,000 Class A ordinary shares (“Class A Ordinary Shares”), at a price of $4.00 per Ordinary Share (the “Offering Price”). The Class A Ordinary Shares began trading on the Nasdaq Capital Market on December 5, 2024 under the symbol “LNKS”. The aggregate gross proceeds from the Offering were $7.6 million, before deducting underwriting discounts and other related expenses. The Company intends to use the net proceeds to acquire companies and/or form joint ventures within the value chain of the wire/cable harnesses industry; to purchase machinery/equipment; to promote marketing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.